Scientific Publication

A biotech's preclinical success in treating miscarriage is just the start. The real story is its strategy of using pregnancy immunology to target cancer.

With a landmark NEJM publication and FDA approval, Rhythm Pharma's setmelanotide offers hope for a rare obesity, proving a potent strategy for niche markets.

A new study validates a blood test with near-perfect accuracy in MS relapse detection, signaling a strategic shift from imaging to biological data in neurology.

For children with the rare metabolic disorder MMA, a new gene therapy offers hope. Preclinical data reveals a potential one-time fix with lifelong effects.

New long-term data shows a 60-day nerve stimulation treatment helps 8 in 10 patients avoid surgery, challenging the entire strategy for chronic pain.

New guidelines for ankle arthritis, a condition hitting younger workers hard, expose major gaps in medical research and a market ripe for innovation.

Artelo's latest data on its non-opioid pain drug ART26.12 could unlock a massive market, but what are the real risks and rewards for this clinical-stage biotech?

A novel CAR-T therapy from UC Irvine and GlyTR Therapeutics uses a 'velcro-like' mechanism to target solid tumors, a major hurdle in modern oncology.

An Oxford startup's AI-powered blood test can detect cancer and heart disease in dogs from a single sample, heralding a shift from reactive to proactive care.

New imaging data provides the first evidence that a drug-app combo for Parkinson's can induce physical changes in the brain, linking digital therapy to better outcomes.

A new chapter in materials science signals a major shift from metal to 3D woven composites, promising lighter, stronger, and more efficient aircraft.

A new study shows Candela's Nordlys laser not only reverses skin aging at a DNA level but may also fight cancer, setting a new bar for the industry.

New data reveals how Genelux’s oncolytic virus reawakens chemotherapy's power, offering a potential lifeline in a notoriously difficult-to-treat cancer.

Cumulus Neuroscience's at-home EEG platform shows remarkable patient adherence, promising to accelerate drug trials and reshape the fight against dementia.

Landmark 2-year study shows an AI diagnostic for diabetic kidney disease actively improves patient outcomes, validating a new era of precision medicine.

A new study reveals how Salipro Biotech's platform makes 'undruggable' membrane proteins accessible, a milestone that could reshape pharmaceutical R&D.

Amorepacific is rewiring K-beauty's DNA, moving from fleeting trends to a robust infrastructure of clinical data and advanced biological delivery systems.

A breakthrough oral vaccine from Singaporean scientists promises to end a devastating fish virus, bolstering food security and transforming aquaculture economics.

While national HIV rates fall, a new Johns Hopkins report reveals how a decade of policy neglect is fueling a devastating surge among Latino communities.

A Virginia nonprofit's AI platform, backed by Pentagon funding, has decoded the deadly impact of radiation on the gut, paving the way for new countermeasures.